Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Antai Biological Pharmaceutical is a Chinese biotechnology company specializing in the research, development, and manufacture of veterinary biological products. Headquartered in Jinzhong, Shanxi Province, the company is a prominent producer of animal vaccines, particularly those targeting brucellosis and rabies. It operates state-of-the-art GMP-certified facilities capable of large-scale production of both live and inactivated vaccines. The company's products are integral to China's national animal disease control programs, serving the livestock and companion animal sectors. By integrating advanced R&D with robust manufacturing capabilities, Shanxi Antai Biological Pharmaceutical maintains a leading position in the regional animal health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Antai Biological Pharmaceutical.